Do you remember about azelastine?

The most common ocular allergy disease is allergic conjunctivitis. Allergic conjunctivitis is reported to affect approximately 20% of general population. It is the result of hypersensitivity response to airborne allergens, pollen, animal dander, fungi (among them molds). It is often underdiagnosed and undertreated. The large surface area of the conjunctiva, a robust vascular supply and a dense concentration of mast cells make allergic conjunctivitis a particularly vexing form of allergy. Nowadays, the dual action agents, among them azelastine, with combines antihistaminic activity with mast cell stabilizing properties are the gold standard for ocular allergy treatment.